Brian Loo - Haw Par Group Mang

All Insiders . USA . 
Stock . Haw Par . Stakeholders . Insider . Brian Loo
HAWPF Stock  USD 8.35  0.00  0.00%   

Insider

Brian Loo is Group Mang of Haw Par
Phone65 6337 9102
Webhttps://www.hawpar.com

Haw Par Management Efficiency

Haw Par's management efficiency ratios could be used to measure how well Haw Par manages its routine affairs as well as how well it operates its assets and liabilities.
Haw Par has accumulated 12.92 M in total debt with debt to equity ratio (D/E) of 0.0, which may suggest the company is not taking enough advantage from borrowing. Haw Par has a current ratio of 7.37, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Haw Par until it has trouble settling it off, either with new capital or with free cash flow. So, Haw Par's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Haw Par sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Haw to invest in growth at high rates of return. When we think about Haw Par's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Tony WoodGlaxoSmithKline PLC ADR
N/A
Charlotte WieserNovartis AG ADR
N/A
Sarah EltonFarrGlaxoSmithKline PLC ADR
N/A
Timothy PowerBristol Myers Squibb
N/A
Thomas HudsonAbbVie Inc
62
Jannie OosthuizenMerck Company
53
Gordon LohPfizer Inc
N/A
Nadim AhmedBristol Myers Squibb
51
Vanessa BroadhurstJohnson Johnson
52
Diana ConradGlaxoSmithKline PLC ADR
N/A
Robert PharmDNovartis AG ADR
56
Diogo RauEli Lilly and
49
Michael FlemingMerck Company
61
Alonzo WeemsEli Lilly and
53
Mike McdermottPfizer Inc
N/A
Martin MIBSEli Lilly and
61
Diane WilfongGilead Sciences
62
Kimberly JohnsonEli Lilly and
48
A WashingtonJohnson Johnson
70
Jonathan SymondsGlaxoSmithKline PLC ADR
62
Christopher StevoPfizer Inc
N/A
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. Haw Par [HAWPF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Return On Equity0.0424
Return On Asset0.0063

Haw Par Leadership Team

Elected by the shareholders, the Haw Par's board of directors comprises two types of representatives: Haw Par inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Haw. The board's role is to monitor Haw Par's management team and ensure that shareholders' interests are well served. Haw Par's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Haw Par's outside directors are responsible for providing unbiased perspectives on the board's policies.
Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd
Kun Chiew, Group Sec
Say Chow, Group Finance Controller
Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited
Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare
Tang Lee, Mang Communications
Tang Chow, Human Director
Brian Loo, Group Mang

Haw Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Haw Par a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0424
Return On Asset0.0063
Profit Margin0.79 %
Operating Margin0.19 %
Current Valuation(701.58 M)
Shares Outstanding221.37 M
Shares Owned By Insiders36.98 %
Shares Owned By Institutions32.30 %
Price To Earning15.92 X
Price To Book0.65 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Haw Pink Sheet

Haw Par financial ratios help investors to determine whether Haw Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Haw with respect to the benefits of owning Haw Par security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY